The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1.
Level 5 - mechanism / opinion, no new human data
Bench and in vitro laboratory study (non-clinical mechanism)
PubMed 19448625 · doi:10.1038/ncb1881
What was done
Researchers investigated the molecular mechanisms regulating low glycolytic rates in cortical neurons compared to astrocytes. They evaluated the expression and proteasomal degradation of the glycolytic regulator Pfkfb3 (6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3) via the E3 ubiquitin ligase APC/C-Cdh1, and tested the metabolic and survival effects of Pfkfb3 overexpression or Cdh1 inhibition in neurons.
What was found
The abstract reports qualitative biochemical findings without specific numerical values. Pfkfb3 was absent in cortical neurons due to constant proteasomal degradation mediated by APC/C-Cdh1, whereas astrocytes maintained low APC/C-Cdh1 activity and detectable Pfkfb3. Upregulating Pfkfb3 (via direct overexpression or Cdh1 inhibition) activated glycolysis in neurons, but caused a marked decrease in glucose flux through the pentose phosphate pathway, resulting in oxidative stress and apoptotic cell death.
Why it matters
This study identifies a core metabolic trade-off in neurons, explaining why they intentionally restrict glycolysis via APC/C-Cdh1: sparing glucose for the pentose phosphate pathway is essential to regenerate reduced glutathione and protect against oxidative damage.
Limits
The abstract provides no quantitative effect sizes, sample counts, or statistical parameters. The experiments are preclinical in vitro/cellular models, and in vivo physiological dynamics in intact brains or under pathological conditions were not detailed in the abstract.
Cited by
- supports Neuronal lactate utilization spares glucose to enter the pentose phosphate pathway, which produces NADPH required for glutathione synthesis in the brain.